immune system
• following exposure to ovalbumin, mice exhibit decreased eosinophil cell numbers in bronchoalveolar lavage compared to wild-type mice
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure
|
• at day 76 of ovalbumin exposure or induction of an acute asthma model, no IL-4 and reduced levels of IL-5 and IL-13 proteins are found in the bronchoalveolar lavage fluid
• however, interleukin response to antigenic stimulation is normal
|
• following exposure to ovalbumin, mice exhibit decreased total inflammatory cells and eosinophils, goblet cell metaplasia/mucus hypersecretion, and edema of airway interstitium compared to wild-type mice
• at day 76 of exposure to ovalbumin, allergen-induced increased smooth muscle cell layer mass and subepithelial fibrosis is decreased compared to in wild-type mice
• however, mice respond normally to methacholine
• at day 76 of exposure to ovalbumin, mice do not produce increased levels of PGE2, PGD2, LTB, or cysLTs as in wild-type mice indicating an impaired eicosanoid release
|
hematopoietic system
• following exposure to ovalbumin, mice exhibit decreased eosinophil cell numbers in bronchoalveolar lavage compared to wild-type mice
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure in bronchoalveolar lavage fluid
|
• at day 29 of ovalbumin exposure
|
homeostasis/metabolism
• at day 76 of exposure to ovalbumin, mice do not produce increased levels of PGE2 or PGD2 as in wild-type mice
|
• at day 76 of ovalbumin exposure or induction of an acute asthma model, no IL-4 and reduced levels of IL-5 and IL-13 proteins are found in the bronchoalveolar lavage fluid
• however, interleukin response to antigenic stimulation is normal
|